Achieve Life Sciences Announces Appointment of Andrew D. Goldberg, MD, as Chief Executive Officer and to the Board of Directors
Achieve Life Sciences has appointed Dr. Andrew D. Goldberg as CEO and added two new healthcare leaders to its board. The move coincides with a substantial financing round of up to $354 million to support the development and potential launch of cytisinicline, a novel treatment for nicotine dependence pending FDA approval. Cytisinicline represents th…